Protalix BioTherapeutics, Inc. Share Price
PLXProtalix BioTherapeutics, Inc. Stock Performance
Open $2.25 | Prev. Close $2.31 | Circuit Range N/A |
Day Range $2.25 - $2.40 | Year Range $1.42 - $3.19 | Volume 50,350 |
Average Traded $2.37 |
Protalix BioTherapeutics, Inc. Share Price Chart
About Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. It operates in the United States, Australia, Canada, Israel, Brazil, Russia, and Turkey. The company is headquartered in Hackensack. New Jersey.
Protalix BioTherapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Jul-26 | $2.25 | $2.38 | +3.03% |
16-Jul-26 | $2.32 | $2.31 | -0.86% |
15-Jul-26 | $2.32 | $2.33 | +0.65% |
14-Jul-26 | $2.36 | $2.31 | -3.14% |
13-Jul-26 | $2.43 | $2.39 | -2.45% |
10-Jul-26 | $2.35 | $2.45 | +3.16% |
09-Jul-26 | $2.38 | $2.38 | -0.21% |
FAQs on Protalix BioTherapeutics, Inc. Share Price
Can I buy Protalix BioTherapeutics, Inc. shares in India?
What is the share price of Protalix BioTherapeutics, Inc.?
What is the 5 year returns of Protalix BioTherapeutics, Inc.?
What are the high & low stock price of Protalix BioTherapeutics, Inc. today?
What is the 52-week high and low of Protalix BioTherapeutics, Inc. stock?